Plasma lipids, HDL and apolipoproteins, and coronary heart disease in men less than 50 years old. A case-control study

Acta Cardiologica

Volumn 53, Issue 5, 1998, Pages 269-273

  Cubero, Gustavo I ^a   Reguero, J Julian R ^a   Batalla, Alberto ^a   Simarro, Eugenio ^a   Posada, Ignacio S ^a   Braga, Socorro ^a   Negrete, José L ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Cholesterol; Early coronary heart disease; HDL; Lipoproteins; Odds ratios

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; APOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMPUTER ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; ELECTROCARDIOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK; RISK FACTOR; SOUTHERN EUROPE; SYMPTOM; VEIN PUNCTURE;

ADULT; APOLIPOPROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 0032419229     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, Tyroler H. Ten-year mortality from cardiovascular disease in relation to cholesterol levels among men with and without preexisting cardiovascular disease. New Engl J Med 1990; 322: 1700-1707.
2. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-364.
3. The Scandinavian Simvastatin Survival Study group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
4. Rangland DR, Brand RJ. Coronary heart disease mortality in the Western collaborative group study. Follow-up experience of 22 years. Am J Epidemiol 1988; 127: 462-475.
5. Dawber TR. The Framingham Study. The Epidemiology of Atherosclerotic disease. Harvard: Harvard University Press, 1980.
6. Stamler J, Wentworth D, Neaton JD. for the MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823-2828.
7. Abbott RD, McGee D. The probability of developing certain cardiovascular disease in eight years as specified values of some characteristics. In: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study. An Epidemiological Investigation of Cardiovascular Disease. Bethesda, MD:US Dept of Health, Education, and Welfare; 1987; 37: Publication NIH 87-2284.
8. Kannel WB, Gordon T, Castelli WP. Role of lipids and lipoprotein fractions in assessing atherogenesis. The Framingham Study. Prog Lipid Res 1981; 20: 339-348.
9. Assman G, Schulte H, von Eckardstein A, Huang I. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implication for reverse cholesterol transport. Atherosclerosis 1996; 124: Suppl.:S11-S20.
10. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. Arterioscler Thromb Vasc Biol 1997; 17: 107-113.
11. Castelli WP, Garrison RJ, Wilson PJ, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986; 256: 2835-2838.
12. Steinberg D, Witztum JL. Lipoproteins and atherogenesis: Current concepts. JAMA 1990; 264: 3047-3052.
13. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-2544.
14. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case control study in a general population sample of middle-aged men. BMJ 1990; 301: 1248-1251.
15. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Standards and procedures for measurement and classification. Boston: PSG. 1982.
16. Report of the Pooling Project. Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project. J Chronic Dis 1978; 32: 201-306.
17. Yaari S, Goldbourt U, Even-Zohar S, Neufeld HN. Associations of serum high density lipoprotein and total cholesterol with total cardiovascular and cancer mortality in a 7-year prospective study of 10,000 men. Lancet 1981; 1: 1011-1014.
18. Van Houte O, Kesteloot H. An epidemiological survey of risk factors for ischemic heart disease in 42,804 men. Acta Cardiol 1972; 27: 527-564.
19. Nobili A. D'Avanzo B, Santoro L, Ventura G., Todesco P, La Vecchia C (on behalf of Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico investigators). Serum cholesterol and acute myocardial infarction: a case-control study from the GISSI-2 trial. Br Heart J 1994; 71: 468-473.
20. Kesteloot H, Geboers J, Pietinen P. On the within-population relationship between dietary habits and serum lipid levels in Belgium. Eur Heart J 1987; 8: 821-831.
21. Banegas JR, Villar F, Perez C, Jimenez R, Gil E, Muñiz J, Juane R. Estudio epidemiológico de los factores de riesgo cardiovascular en la población española de 35-64 años. Rev San Pub 1993; 67: 419-445.
22. Segura A, de Mateo S, Gutierrez J. Epidemiología de los factores de riesgo cardiovascular en un area rural de la region de Castilla la Mancha. Gac sanit 1997; 11(Suppl): 47.
23. Assman G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992; 70: 733-737.
24. Austin MA. Plasma triglyceride and coronary heart disease. Arteriosclerosis 1991; 11: 2-14.
25. Bottiger LE, Carlson LA. Risk factors for ischaemic vascular death for men in the Stockholm Prospective Study. Atherosclerosis 1990; 36: 389-408.
26. Welin L, Ericksson H, Larsson B, Ohlson LO, Svardsudd K, Tibblin G, Wilhelmsen L. Triglycerides, a major coronary risk factor in elderly men. A study of men born in 1913. Eur Heart J 1991; 12: 700-704.
27. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112: 432-437.
28. Reinhart RA, Gani K, Arndt MR, Broste SK. Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease. Arch Intern Med 1990; 150: 1629-1633.
29. 1-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230-235.
30. Loscalzo J, Weinfeld M, Gless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis 1990; 10: 240-245.
31. McCall M, Elmfeldt D, Veding A, Wilhelmsson C, Wedel H, Wilhemsen L. Influence of myocardial infarction on blood pressure and serum cholesterol. Acta Med Scand 1979; 206: 477-481.
32. Cooper GR, Myers GL, Smith SU, Schlant RD. Blood lipid measurements variations and practical utility. JAMA 1992; 267: 1652-1660.